 |
|
|
 |
|
|
 |
|
|
| Cortex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs called AMPAKINE molecules targeted towards human central nervous system diseases. AMPAKINE molecules represent a new approach to treating psychiatric disorders, neurological diseases and brain mediated breathing disorders. AMPAKINE compounds are small drug-like molecules that positively modulate the AMPA-type glutamate receptor complex, amplifying the effect of the most prominent brain neurotransmitter, glutamate leading to excitation of multiple brain circuits that effect learning and memory, attention, and a unique brain stem structure thought to be responsible for maintaining breathing. |
|
|
|
|
|
|
